First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer.

Autor: Mercinelli, Chiara, Moschini, Marco, Cigliola, Antonio, Mattorre, Benedetta, Tateo, Valentina, Basile, Giuseppe, Cogrossi, Laura L., Maiorano, Brigida A., Patanè, Damiano A., Raggi, Daniele, Pastorino, Giovanni L., Re, Chiara, Colecchia, Maurizio, Lucianò, Roberta, Colombo, Renzo, Brembilla, Giorgio, De Cobelli, Francesco, Briganti, Alberto, Pavlick, Dean C., Ross, Jeffrey S.
Zdroj: Journal of Clinical Oncology; 12/10/2024, Vol. 42 Issue 35, p4196-4205, 17p
Databáze: Supplemental Index